Kim H S, Lee I H, Jeon Y J, Chung C H, Ha D B
Department of Molecular Biology and SRC for Cell Differentiation, College of Natural Sciences, Seoul National University, Korea.
Exp Cell Res. 1993 Apr;205(2):408-11. doi: 10.1006/excr.1993.1105.
Sphingosine, a potent inhibitor of protein kinase C, was found to block membrane fusion of chick embryonic myoblasts in culture. This effect was dose-dependent and could be reversed upon removal of the drug. Treatment with 12-O-tetradecanoylphorbol 13-acetate, which is a powerful activator of protein kinase C and capable of preventing myoblast fusion, further potentiated the inhibitory effect of sphingosine. Thus, the sphingosine-mediated inhibition of myoblast fusion appears to be independent of protein kinase C. Sphingosine also decreased the phosphorylation state of the 100-kDa protein when given to the cell extracts, and this inhibition was competitive with calmodulin. Thus, sphingosine seems to act as a calmodulin antagonist. These results suggest that the sphingosine-mediated inhibition of myoblast fusion may be associated with the inhibitory effect of the drug against the calmodulin-dependent phosphorylation of the 100-kDa protein.
鞘氨醇是一种有效的蛋白激酶C抑制剂,已发现它能阻断培养的鸡胚成肌细胞的膜融合。这种作用呈剂量依赖性,且在去除药物后可逆转。用12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯处理,它是一种强大的蛋白激酶C激活剂,能够阻止成肌细胞融合,进一步增强了鞘氨醇的抑制作用。因此,鞘氨醇介导的成肌细胞融合抑制似乎与蛋白激酶C无关。当将鞘氨醇加入细胞提取物时,它还降低了100 kDa蛋白的磷酸化状态,并且这种抑制作用与钙调蛋白具有竞争性。因此,鞘氨醇似乎起着钙调蛋白拮抗剂的作用。这些结果表明,鞘氨醇介导的成肌细胞融合抑制可能与该药物对100 kDa蛋白的钙调蛋白依赖性磷酸化的抑制作用有关。